SAB4501264
Anti-RNF149 antibody produced in rabbit
affinity isolated antibody
Synonym(s):
DNA polymerase-transactivated protein 2, E3 ubiquitin-protein ligase RNF149, RING finger protein 149
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
polyclonal
Application:
ELISA, IHC
Citations:
1
biological source
rabbit
Quality Level
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
antigen 43 kDa
species reactivity
human, mouse
concentration
~1 mg/mL
technique(s)
ELISA: 1:10000, immunohistochemistry: 1:50-1:100
NCBI accession no.
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... RN149(284996)
General description
Anti-RNF149 Antibody detects endogenous levels of total RNF149 protein.
Immunogen
The antiserum was produced against synthesized peptide derived from human RNF149.
Immunogen Range: 211-260
Immunogen Range: 211-260
Features and Benefits
Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.
Physical form
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Still not finding the right product?
Explore all of our products under Anti-RNF149 antibody produced in rabbit
— or —
Try our Product Selector Tool to narrow your options
Storage Class
10 - Combustible liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
常规特殊物品
低风险生物材料
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Jinrong Zhu et al.
Medical oncology (Northwood, London, England), 40(10), 290-290 (2023-09-04)
Chemo-resistance has been identified as a crucial factor contributing to tumor recurrence and a leading cause of worse prognosis in patients with ESCC. Therefore, unravel the critical regulators and effective strategies to overcome drug resistance will have a significant clinical
Global Trade Item Number
| SKU | GTIN |
|---|---|
| SAB4501264-100UG | 04061835723201 |